Aggregated News
Top University officials allegedly manipulated a Perelman School of Medicine investigation into years of workplace abuse allegations within the Gene Therapy Program in order to protect its financial interests and director Jim Wilson, according to internal reports obtained by The Daily Pennsylvanian.
Following our previous reporting on GTP’s toxic workplace environment, based upon testimonies of 11 current and former GTP employees, the DP obtained a selection of documents alleging that Penn administrators covered up a lengthy investigation into the program’s workplace and its leadership.
The initial 21-page report detailing this investigation’s findings was ultimately slimmed down to a four-page draft following intervention from Penn’s Office of General Counsel, with the fifth and final draft devoid of all allegations against Wilson and GTP’s Executive Director of Research Administration Monique Molloy. The Office of General Counsel represents Penn and Penn Medicine in legal matters, and initiates action to protect the institution and manage risks, according to its website.
Time and again, employees have alleged that Penn is protecting Wilson and GTP by burying the grievances of the program’s lower-level employees, since the...
